Marc Pracht
Marc Pracht publishes mostly in Oncology, Hepatology and Pulmonary and Respiratory Medicine, on topics such as Hepatocellular Carcinoma Treatment and Prognosis, Cholangiocarcinoma and Gallbladder Cancer Studies and Cutaneous Melanoma Detection and Management.
- World rank
- #653,687 of 7,710,434 ranked researchers
- Rank in France
- #32,745 of 324,115
- Works
- 206
- Citations
- 12k
- Citations per work
- 58.7
What does Marc Pracht research?
Marc Pracht's work is mostly in Medicine (67%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences13866.9%
- Medicine13866.9%
- Everything else6833.1%
- 1Oncology18% of their works
- 2Hepatology16% of their works
- 3Pulmonary and Respiratory Medicine13% of their works
- 4Surgery8% of their works
- 5Epidemiology6% of their works
- 6Radiology, Nuclear Medicine and Imaging6% of their works
Research topics
- Hepatocellular Carcinoma Treatment and Prognosis
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Cutaneous Melanoma Detection and Management
- Gastrointestinal Tumor Research and Treatment
- Cancer Immunotherapy and Biomarkers
- Radiopharmaceutical Chemistry and Applications
- Melanoma and MAPK Pathways
- Pancreatic and Hepatic Oncology Research
Which keywords describe Marc Pracht's research?
The keywords of their largest research topics: Hepatocellular Carcinoma, Liver Cancer, Epidemiology, Prognostic Factors, Surgical Management, Melanoma, PET Imaging and Immunotherapy.
- Pancreatic Cancer
- BRAF gene
- Sunitinib
- PD-1 and PD-L1
- Imatinib Mesylate
- Dermoscopy
- Biliary Tract Cancer
- Immunotherapy
- Melanoma
- Prognostic Factors
- Liver Cancer
- Hepatocellular Carcinoma
- Epidemiology
- Surgical Management
- PET Imaging
- Tumor Microenvironment
- Cholangiocarcinoma
- Skin Cancer
- Immune Checkpoint Blockade
- Radiopharmaceuticals
- Targeted Therapy
- MAP Kinase
- Surgical Complications
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 23 words, with their numbers
- Hepatocellular Carcinoma631 topic
- Liver Cancer631 topic
- Epidemiology372 topics
- Prognostic Factors362 topics
- Surgical Management362 topics
- Melanoma302 topics
- PET Imaging302 topics
- Immunotherapy292 topics
- Tumor Microenvironment282 topics
- Biliary Tract Cancer211 topic
- Cholangiocarcinoma211 topic
- Dermoscopy161 topic
- Skin Cancer161 topic
- Imatinib Mesylate151 topic
- Immune Checkpoint Blockade151 topic
- PD-1 and PD-L1151 topic
- Radiopharmaceuticals151 topic
- Sunitinib151 topic
- Targeted Therapy151 topic
- BRAF gene141 topic
- MAP Kinase141 topic
- Pancreatic Cancer131 topic
- Surgical Complications131 topic
Where does Marc Pracht work?
Marc Pracht's main affiliation in the publication record is Centre Eugène Marquis, France.
How many publications and citations does Marc Pracht have?
OpenAlex counts 206 works and 12,093 citations for Marc Pracht, an h-index of 36, ranking #653,687 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Marc Pracht. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.